Invention Grant
US08410136B2 Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione 有权
使用3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基) - 哌啶-2,6-二酮处理肝细胞癌的方法

  • Patent Title: Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
  • Patent Title (中): 使用3-(4-氨基-1-氧代-1,3-二氢异吲哚-2-基) - 哌啶-2,6-二酮处理肝细胞癌的方法
  • Application No.: US12755904
    Application Date: 2010-04-07
  • Publication No.: US08410136B2
    Publication Date: 2013-04-02
  • Inventor: Jerome B. Zeldis
  • Applicant: Jerome B. Zeldis
  • Applicant Address: US NJ Summit
  • Assignee: Celgene Corporation
  • Current Assignee: Celgene Corporation
  • Current Assignee Address: US NJ Summit
  • Agency: Jones Day
  • Main IPC: A01N43/40
  • IPC: A01N43/40
Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
Abstract:
Methods of treating, preventing and/or managing cancer as well as and diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Information query
Patent Agency Ranking
0/0